Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trivalent Chromium as a Treatment for Rheumatoid Arthritis Patients

NCT05545020 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT05545020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05545020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trivalent Chromium as a Treatment for Rheumatoid Arthritis Patients
Lead sponsor
Alexandria University
Phase
Phase 2/3
Overall status
Completed
Start date
December 25, 2022
Completion date
January 13, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis